Showing results (391-400 of 424) with videos related to

Sort By:
Pageof 43
The Lancet. Infectious Diseases|March 22, 2025
Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trialTsiri Agbenyega, Anne E Schuind, Samuel Adjei, et al.
Vaccines|June 25, 2026
Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai AdultsKriengkrai Prasert, Sutthichai Nakphook, Jiraphut Kittiwatanachod, et al.
The Lancet. Infectious Diseases|August 16, 2025
Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trialLaina D Mercer, Arlene C Seña, E Ross Colgate, et al.
The Lancet. Microbe|November 4, 2022
Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trialsRahnuma Wahid, Laina D Mercer, Tirza De Leon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2026
Persistence of Serum Bactericidal Antibody in the First 2-Years After Immunization with Pentavalent Meningococcal ACWYX Vaccine in Malian Infants and ToddlersWilbur H Chen, Fadima C Haidara, Fatoumata Diallo, et al.
Vaccine|February 6, 2023
Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized studyRahsan Erdem, Ilse De Coster, Kanchanamala Withanage, et al.
Vaccine|November 30, 2024
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trialVu Dinh Thiem, Dang Duc Anh, Vu Hai Ha, et al.
Advances in Nutrition (Bethesda, Md.)|April 10, 2021
Healthy Aging-Nutrition Matters: Start Early and Screen OftenSusan B Roberts, Rachel E Silver, Sai Krupa Das, et al.
Archives of General Psychiatry|August 1, 1997
The National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Rationale and methodsP Crits-Christoph, L Siqueland, J Blaine, et al.
The Lancet. Global Health|November 15, 2025
Safety and non-inferiority of multidose and single-dose vial formulations of EuTCV Vi-CRM197 versus Typbar TCV in healthy participants in Kenya and Senegal: a multicentre, observer-blind, randomised, phase 3 studyBirahim Pierre Ndiaye, Lucy Koech, Laina D Mercer, et al.
Pageof 43